Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1992-05-26
1999-12-14
Weber, Jon P.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9463, 435212, A61K 3848, A61K 3849, C12N 948, C12N 964
Patent
active
060013559
ABSTRACT:
Pro-tPA has a higher affinity for fibrin and better selectivity than tPA and is used for the management and prophylaxis of thrombosis, embolism, and related conditions. A pharmaceutical composition comprises a physiological compatible medium and pro-tPA employed in a couple of 70-100% pro-tPA and 0-30% of tPA.
REFERENCES:
patent: 4165258 (1979-08-01), Pye et al.
patent: 4245051 (1981-01-01), Reich et al.
patent: 4552760 (1985-11-01), Murakami et al.
patent: 4898825 (1990-02-01), Morii et al.
patent: 4960702 (1990-10-01), Rice et al.
patent: 4978620 (1990-12-01), Morii et al.
patent: 5288490 (1994-02-01), Budzynski et al.
patent: 5316766 (1994-05-01), Baldus et al.
patent: 5496549 (1996-03-01), Yamazaki et al.
Granelli-Piperno et al., J. Exp. Med., 148(1), "A Study of Proteases and Protease-Inhibitor Complexes in Biological Fluids", pp. 223-234, Jul. 1978.
Binder et al., J. Biol. Chem., 254(6), "Purification and Characterization of Human Vascular Plasminogen Activator Derived from Blood Vessel Perfusates", pp. 1998-2003, Mar. 1979.
Heussen, C. An inhibitor of Tissue Plasminogen Activator Isolated from the Seeds of the South African Tree, Erythrina latissima, 6.sup.th Int. Congress of Fibrinolysis, Lausanne, Switzerland Jul. 20-23, 1982 Haimostasis 1 (Suppl 1) 1982.42.
Heussen et al., "Purification of Human Tissue Plasminogen Activator with Erythrina trypsin Inhibitor", J. Biol. Chem. vol. 259, No. 19, Oct. 10, 1984; pp. 11,635-11,638.
Heussen et al., "An Inhibitor of Tissue Plasminogen Activator Isolated from the Seeds of the South African Tree, Erythrina latissima",; 6.sup.th International Congress of Fribinolysis, Lausanne, Switzerland, Jul. 20-23, 1982. Haemostascis 11 (Suppl. 1), 1982, p. 47.
Rijken et al., "Fibrinolytic Properties of One-Chain and Two-Chain Human Extrinsic (Tissue-type) Plasminogen Activator", J. Biol. Chem., vol. 257, No. 6, Mar. 25, 1982; pp. 2920-2925.
Collen, D., "Synergism of Tissue-type Plasminogen . . . this Effect", Thrombosis and Haemostasis, vol. 37(3), p. 373, 1987.
LandOfFree
Pro-tPA for the treatment of thrombosis, embolism and related co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pro-tPA for the treatment of thrombosis, embolism and related co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro-tPA for the treatment of thrombosis, embolism and related co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-860463